Knowledge HQ

Publications
Publications

BRAF targeting sensitizes resistant melanoma to cytotoxic T cells

The study investigates combining BRAF inhibitors with TIL therapy for resistant melanoma. In the associated clinical trial, patient TILs were rapidly expanded in G-Rex, facilitating the combination therapy approach.
Download Now
Publications

Phase 1 Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma

This Phase 1 trial demonstrated the safety of NKG2D CAR-T cells in hematologic cancers. G-Rex were used for the ex vivo expansion of CAR-T cells during the 9-day manufacturing process, ensuring sufficient cell yield for infusion.
Download Now
Publications

Large-scale expansion of Vγ9Vδ2 T cells with engineered K562 feeder cells in G-Rex vessels and their use as chimeric antigen receptor– modified effector cells

A method to expand Vγ9Vδ2 T cells using engineered K562 aAPCs was optimized in G-Rex vessels. The G-Rex platform enabled the generation of large numbers of functional gamma-delta T cells suitable for CAR modification and allogeneic therapy.
Download Now
Publications

Enabling Large-Scale Ex Vivo Production of Megakaryocytes from CD34+ Cells Using Gas-Permeable Surfaces

This study evaluated G-Rex culture systems for producing megakaryocytes from CD34+ cells. G-Rex cultures with optimized seeding densities significantly increased the expansion of Mk progenitors and overall yield compared to standard tissue culture surfaces.
Download Now
Publications

Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma

This study identified neoepitopes recognized by TILs from glioblastoma patients. G-Rex were used to expand TILs from tumor digests in the presence of OKT3 and irradiated feeder cells, providing sufficient cells for immune reactivity testing.
Download Now
Publications

TCRαβ/CD3 disruption enables CD3-specific antileukemic T cell immunotherapy

This paper reports the creation of anti-CD3 CAR-T cells (3CAR) using TALEN-mediated TCR disruption to avoid self-killing. G-Rex were used to scale up the production, allowing 3CAR T cells to expand 100-fold and self-enrich for the TCR-negative population.
Download Now
Publications

Utilizing T-cell activation signals 1, 2 and 3 for tumor-infiltrating lymphocytes (TIL) expansion: the advantage over the sole use of interleukin-2 in cutaneous and uveal melanoma

A novel TIL expansion method combining IL-2, anti-4-1BB, and OKT3 was developed. Using small G-Rex 10 devices allowed for successful expansion from fewer tumor fragments and reduced culture time compared to standard methods, especially for uveal melanoma.
Download Now
Publications

Manufacturing development and clinical production of NKG2D Chimeric Antigen Receptor-expressing T cells for autologous adoptive cell therapy

A 9-day manufacturing process for NKG2D CAR-T cells was developed for a Phase I trial. G-Rex 100 were utilized for the ex vivo expansion step, enabling the production of therapeutic doses of viable and functional CAR-T cells from patient material.
Download Now
Publications

Efficient Enrichment of Gene-Modified Primary T Cells via CCR5-Targeted Integration of Mutant Dihydrofolate Reductase

The study demonstrates a method to enrich gene-edited CD4+ T cells using methotrexate selection. G-Rex 10 were employed for the long-term expansion of lentivirus-modified T cells, facilitating the generation of large numbers of selected cells.
Download Now
Publications

CMV and EBV targets recognized by tumor-infiltrating B lymphocytes in pancreatic cancer and brain tumors

The study explores antibody responses from tumor-infiltrating B cells against viral antigens in cancer patients. G-Rex were used to expand tumor-infiltrating lymphocytes (TILs) from tumor tissue, facilitating the analysis of immune reactivity in the tumor microenvironment.
Download Now
Publications

Enhanced Expression of Anti-CD19 Chimeric Antigen Receptor in piggyBac Transposon-Engineered T Cells

This paper describes an improved method for generating CAR-T cells using the piggyBac transposon system. G-Rex10 culture were used for the expansion phase, contributing to the generation of clinically relevant numbers of CAR-T cells with a memory phenotype.
Download Now
Publications

Generation of Tumor-Specific (tg-TCR) T Cells Using CRISPR-Mediated In-Locus Insertion Combined with Endogenous TCR Knockout

This study demonstrates a method for generating tumor-specific TCR-T cells using CRISPR/Cas9 for endogenous TCR knockout and AAV for TCR insertion. G-Rex 24-well plates were utilized for T cell expansion, supporting cell viability and growth during the editing process.
Download Now

ScaleReady is a joint venture between Wilson Wolf Manufacturing and Bio-Techne.